InflaRx NV (IFRX)
2.50
+0.03
(+1.21%)
USD |
NASDAQ |
May 18, 16:00
2.46
-0.04
(-1.60%)
After-Hours: 20:00
InflaRx Total Liabilities (Quarterly) : 13.83M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Liminatus Pharma, Inc. | 2.923M |
| Oruka Therapeutics, Inc. | 17.76M |
| MapLight Therapeutics, Inc. | 18.95M |
| Kailera Therapeutics, Inc. | -- |
| QIAGEN NV | 2.450B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 56.33M |
| Shareholders Equity (Quarterly) | 42.50M |
| Debt to Equity Ratio | 0.0223 |
| Current Ratio | 4.161 |
| Net Debt Paydown Yield | 0.04% |